Pfizer Inc. and The Pfizer Foundation announced the commitment of $40 million in medical and charitable cash grants to help combat the global health effects of the COVID-19 pandemic in the U.S. and around the world. The donation addresses “the urgent needs of partners who are working to slow the spread of the virus within […]
The U.S. Environmental Protection Agency fined Pfizer Pharmaceuticals, LLC $190,000 for not disclosing chemical information at its plant in Barceloneta as required by the federal Clean Air Act’s chemical accident prevention, chemical safety, and risk management requirements.
Despite an announcement to the contrary, Pfizer’s manufacturing plant in the municipality of Barceloneta will remain open and may be assigned new products in the near future.
The U. S. Environmental Protection Agency announced Monday it has settled a case with Pfizer Pharmaceuticals LLC for violations of the Clean Air Act at the company’s pharmaceutical manufacturing plant in Barceloneta.
As part of a global effort to better align manufacturing capacity with the future needs of its business, Pfizer announced Wednesday the phased shutdown of its Barceloneta manufacturing plant by the end of 2017.
Less than four months after confirming plans to pick up the assets of the former Pfizer manufacturing plant in Caguas, Neolpharma officially inaugurated Tuesday its first operation on U.S. soil and the second established outside its native Mexico.
Mexico’s Neolpharma will be picking up the assets of Pfizer’s Caguas manufacturing plant, through an agreement that is expected to close during the first quarter of 2013, company executives announced Tuesday. The financial terms of the agreement were not disclosed.
Things are not always what they seem, and in the case of counterfeit drugs, knowing the difference between what’s real and what isn’t could be a matter of life and death. With that in mind, pharmaceutical giant Pfizer launched an educational campaign this week to teach Puerto Rican consumers about the negative side of counterfeit medications, whose production and use is a growing global trend.
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
NIMB ON SOCIAL MEDIA